Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07002762

Clinical Efficacy Trial of Burdock Root Extract in Patients With Asymptomatic Hyperuricaemia

Multicentre, Double-blind, Randomized, Placebo-controlled Trial of Clinical Efficacy of Burdock Root Extract in Patients With Asymptomatic Hyperuricaemia

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
OMNIFARMA LLC · Industry
Sex
All
Age
35 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Multicentre, double-blind, randomized, placebo-controlled trial of the clinical efficacy of burdock root extract in patients with asymptomatic hyperuricemia, with the primary objective to assess the efficacy of the use of burdock root extract in patients with asymptomatic hyperuricaemia versus placebo

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTBurdock ( Arctium lappa L.) root extract in a form of a nutritional additiveGastric soluble capsules each containing: 750 mg of burdock ( Arctium lappa L.) root extract in the form of a nutritional additive
OTHERPlaceboGastric soluble capsules each containing: Maltodextrin, silicon dioxide, calcium stearate, food colourants

Timeline

Start date
2025-03-12
Primary completion
2025-09-30
Completion
2025-09-30
First posted
2025-06-04
Last updated
2025-07-30

Locations

1 site across 1 country: Ukraine

Source: ClinicalTrials.gov record NCT07002762. Inclusion in this directory is not an endorsement.